Adjuvant therapy in adrenocortical carcinoma: prognostic factors and treatment options
Adrenocortical carcinoma (ACC) is a rare cancer with high recurrence rates and heterogeneous clinical behavior. The role of adjuvant therapy remains unclear because of the challenges in collecting high-quality data for a rare cancer. The current treatment recommendations and guidelines for adjuvant...
Main Authors: | Ruaa Al-Ward, Celeste Zsembery, Mouhammed Amir Habra |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2023-01-01
|
Series: | Endocrine Oncology |
Subjects: | |
Online Access: | https://eo.bioscientifica.com/view/journals/eo/2/1/EO-22-0050.xml |
Similar Items
-
Adjuvant Therapy in Adrenocortical Carcinoma: Reflections and Future Directions
by: Sara Bedrose, et al.
Published: (2020-02-01) -
Adrenocortical carcinoma: Diagnosis, prognostic classification and treatment of localized and advanced disease
by: Rossella Libé, et al.
Published: (2023-01-01) -
Recovery of Adrenal Insufficiency Is Frequent After Adjuvant Mitotane Therapy in Patients with Adrenocortical Carcinoma
by: Jonathan Poirier, et al.
Published: (2020-03-01) -
A case of adrenocortical carcinoma accompanying secondary acute adrenal hypofunction postoperation
by: Kai Kou, et al.
Published: (2018-03-01) -
Characterization of hyperlipidemia secondary to mitotane in adrenocortical carcinoma
by: Nadia Gagnon, et al.
Published: (2023-01-01)